A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

Overview of attention for article published in BMC Medicine, September 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

So far, Dimensions has found 17 publications that cite this research output.

Article in Clinical Microbiology and Infection (February 2024)

Article in RSC Medicinal Chemistry (January 2024)

Article in Cancers (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.